Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer. (Cancer gene therapy, 2005)

(untitled) - Rochester, M; Riedemann, J; Hellawell, G; Brewster, S; Macaulay, V